Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT00316940 · COMPLETED

Trial details

NCT number: NCT00316940
Sponsor: Oncotherapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2005-12-01
Primary completion: 2008-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.